Takeda Pharmaceutical Company Limited (TAK) Total Assets by Year
Takeda Pharmaceutical Company Limited closed fiscal year 2025 with $95.1B in total assets, $48.8B in total liabilities and $46.3B in shareholder equity. Total assets fell 4.9% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Takeda Pharmaceutical Company Limited has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TAK Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $95.1B-4.9% | $99.9B-5.0% | $105.1B-3.1% | $108.5B-7.0% | $116.7B-2.1% | $119.2B-4.3% | $124.6B+222.3% | $38.7B | N/A |
| Total Liabilities | $48.8B-5.8% | $51.8B-9.5% | $57.3B-7.2% | $61.7B-11.8% | $69.9B-7.1% | $75.3B-3.2% | $77.8B+295.3% | $19.7B | N/A |
| Total Equity | $46.3B-3.8% | $48.1B+0.5% | $47.9B+2.3% | $46.8B+0.1% | $46.8B+6.5% | $43.9B-6.2% | $46.8B+148.9% | $18.8B+7.5% | $17.5B |
TAK Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q4'2420-F | Q4'2320-F | Q4'2220-F | Q4'2120-F | Q4'2020-F | Q4'1920-F | Q4'1820-F |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $95.1B-4.9% | $99.9B-5.0% | $105.1B-3.1% | $108.5B-7.0% | $116.7B-2.1% | $119.2B-4.3% | $124.6B+222.3% | $38.7B |
| Total Liabilities | $48.8B-5.8% | $51.8B-9.5% | $57.3B-7.2% | $61.7B-11.8% | $69.9B-7.1% | $75.3B-3.2% | $77.8B+295.3% | $19.7B |
| Total Equity | $46.3B-3.8% | $48.1B+0.5% | $47.9B+2.3% | $46.8B+0.1% | $46.8B+6.5% | $43.9B-6.2% | $46.8B+148.9% | $18.8B |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Takeda Pharmaceutical Company Limited financials
Frequently Asked Questions
What was Takeda Pharmaceutical Company Limited's total assets in fiscal year 2025?
Takeda Pharmaceutical Company Limited closed fiscal year 2025 with $95.1B in total assets, $48.8B in total liabilities and $46.3B in shareholder equity.
How fast is Takeda Pharmaceutical Company Limited's total assets growing?
Takeda Pharmaceutical Company Limited (TAK) total assets fell by 4.9% year over year, from $99.9B to $95.1B in fiscal year 2025.
What was Takeda Pharmaceutical Company Limited's total assets in the most recent quarter?
Takeda Pharmaceutical Company Limited (TAK) reported $95.1B in total assets in Q4 2025. This represents a decrease of 4.9% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Takeda Pharmaceutical Company Limited (TAK) reported on that line in every period on record.